Literature DB >> 8976763

Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.

H Yokogi1, Y Wada, N Moriyama-Gonda, M Igawa, T Ishibe.   

Abstract

OBJECTIVE: To investigate the relationship between genomic heterogeneity and tumour grade, stage and DNA content in 30 transitional cell carcinomas (TCCs) of the urinary bladder.
MATERIALS AND METHODS: Tissue specimens from 30 patients (25 men and five women) with newly diagnosed TCC of the urinary bladder were examined for genomic heterogeneity using fluorescence in situ hybridization (FISH) with chromosome-specific DNA probes; the copy number of pericentromeric sequences on chromosomes 7, 9 and 17 was detected within interphase nuclei in contact preparations from the tumour specimens.
RESULTS: The aneusomy of chromosomes 7, 9 and 17 was significantly higher in aneuploid than in diploid tumours (P < 0.001). Tumour grade and stage were strongly associated with aneusomy for chromosome 17 (P < 0.01, P < 0.001, respectively). The aneusomy of chromosomes 7 and 9 were significantly correlated with increasing tumour stage (P < 0.001), but not with tumour grade.
CONCLUSION: These results suggest that the measurement of aneusomy using FISH, especially for chromosome 17, in bladder cancer may offer a new objective and quantitative assay of the biological potential of individual tumours.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8976763     DOI: 10.1046/j.1464-410x.1996.01786.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

Review 1.  Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?

Authors:  Samir P Shirodkar; Vinata B Lokeshwar
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

2.  Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.

Authors:  Y Wada; M Igawa; H Shiina; K Shigeno; H Yokogi; S Urakami; T Yoneda; R Maruyama
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

3.  One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection.

Authors:  Rima Tinawi-Aljundi; Lauren King; Shannon T Knuth; Michael Gildea; Carrie Ng; Josh Kahl; Jacqueline Dion; Chris Young; Edward W Schervish; J Rene Frontera; Jason Hafron; Kenneth M Kernen; Robert Di Loreto; Joan Aurich-Costa
Journal:  Res Rep Urol       Date:  2015-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.